Assignee profile:

BioLineRx Ltd.

City:

ModiIn

Country:

Israel

Published Applications:

40

Last publication date:

2025-06-19

Patent Grants:

17

Last grant date:

2025-03-25

Top Inventors for applications by BioLineRx Ltd.

These are the the leading inventors for applications assigned to BioLineRx Ltd.:

Recent patent applications by BioLineRx Ltd.

BioLineRx Ltd. based in ModiIn, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-19
US20250195607A1
Human necessities

COMPOSITION OF BL-8040

#2 | 2025-05-29
US20250170208A1
Human necessities

COMPOSITION OF BL-8040

#3 | 2025-05-29
US20250170207A1
Human necessities

COMPOSITION OF BL-8040

#4 | 2025-05-29
US20250170206A1
Human necessities

COMPOSITION OF BL-8040

#5 | 2025-05-29
US20250170205A1
Human necessities

COMPOSITION OF BL-8040

#6 | 2024-04-25 ✅ Patent 12,257,285 granted on 2025-03-25
US20240131111A1
Human necessities

Composition of BL-8040

#7 | 2024-03-21 ✅ Patent 11,993,631 granted on 2024-05-28
US20240092827A1
Chemistry; metallurgy

Process for manufacturing peptide

#8 | 2024-03-14 ✅ Patent 12,268,725 granted on 2025-04-08
US20240082348A1
Human necessities

Composition of BL-8040

#9 | 2023-08-03
US20230242644A1
Chemistry; metallurgy

TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA

#10 | 2023-04-06
US20230104343A1
Chemistry; metallurgy

CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND VIRAL INFECTIONS

#11 | 2022-09-15
US20220288155A1
Human necessities

CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND VIRAL INFECTIONS

#12 | 2022-03-10
US20220072087A1
Human necessities

SPECIFIC COMBINATION THERAPY FOR TREATMENT OF PANCREATIC CANCER

#13 | 2022-01-13 ✅ Patent 12,291,570 granted on 2025-05-06
US20220010016A1
Chemistry; metallurgy

Treatment of metastatic pancreatic adenocarcinoma

#14 | 2021-11-04
US20210338767A1
Human necessities

METHODS OF SELECTING TREATMENT FOR CXCR4-ASSOCIATED CANCER

#15 | 2021-04-29
US20210121491A1
Human necessities

AGI-134 COMBINED WITH A CHECKPOINT INHIBITOR FOR THE TREATMENT OF SOLID TUMORS

#16 | 2020-12-17
US20200390855A1
Human necessities

COMPOSITIONS, ARTICLES OF MANUFACTURE AND METHODS FOR TREATING CANCER

#17 | 2020-09-24
US20200297812A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#18 | 2020-09-24
US20200297811A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#19 | 2020-09-24
US20200297810A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#20 | 2020-09-24
US20200297808A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#21 | 2020-09-24 ✅ Patent 11,590,200 granted on 2023-02-28
US20200297807A1
Human necessities

Compositions and methods for treating cancer

#22 | 2020-09-24 ✅ Patent 11,638,743 granted on 2023-05-02
US20200297806A1
Human necessities

Compositions and methods for treating cancer

#23 | 2020-09-24 ✅ Patent 11,612,638 granted on 2023-03-28
US20200297805A1
Human necessities

Compositions and methods for treating cancer

#24 | 2020-09-24 ✅ Patent 11,607,444 granted on 2023-03-21
US20200297804A1
Human necessities

Compositions and methods for treating cancer

#25 | 2020-09-24 ✅ Patent 11,554,159 granted on 2023-01-17
US20200297803A1
Human necessities

Compositions and methods for treating cancer

#26 | 2020-09-24 ✅ Patent 11,559,562 granted on 2023-01-24
US20200297802A1
Human necessities

Compositions and methods for treating cancer

#27 | 2020-09-10
US20200282009A1
Human necessities

METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION

#28 | 2020-08-27
US20200268846A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#29 | 2020-08-27 ✅ Patent 11,596,666 granted on 2023-03-07
US20200268845A1
Human necessities

Compositions and methods for treating cancer

#30 | 2020-08-27
US20200268844A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#31 | 2020-08-27 ✅ Patent 11,642,393 granted on 2023-05-09
US20200268843A1
Human necessities

Compositions and methods for treating cancer

#32 | 2020-08-27 ✅ Patent 11,648,293 granted on 2023-05-16
US20200268842A1
Human necessities

Compositions and methods for treating cancer

#33 | 2020-08-27 ✅ Patent 11,638,742 granted on 2023-05-02
US20200268841A1
Human necessities

Compositions and methods for treating cancer

#34 | 2020-08-27 ✅ Patent 11,534,478 granted on 2022-12-27
US20200268840A1
Human necessities

Compositions and methods for treating cancer

#35 | 2019-02-07
US20190038703A1
Human necessities

METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION

#36 | 2018-12-06
US20180344801A1
Human necessities

METHODS OF TREATING MYELOID LEUKEMIA

#37 | 2018-11-01
US20180311308A1
Human necessities

METHODS OF TREATING MYELOID LEUKEMIA

#38 | 2018-06-14
US20180161366A1
Human necessities

METHODS OF OBTAINING MONONUCLEAR BLOOD CELLS AND USES THEREOF

#39 | 2018-05-24 ✅ Patent 10,786,547 granted on 2020-09-29
US20180140670A1
Human necessities

Compositions, articles of manufacture and methods for treating cancer

#40 | 2018-05-24 ✅ Patent 10,682,390 granted on 2020-06-16
US20180140660A1
Human necessities

Compositions and methods for treating cancer

Also check out BioLineRx Ltd.'s (ModiIn, Israel) applicant profile with 12 patent applications submitted.

AssigneeID:

136000 ⎘